Adco-Napamol Tablets (paracetamol)

Home > Adco-Napamol Tablets (paracetamol)

27 Apr Adco-Napamol Tablets (paracetamol)

Posted at 12:45h in by
Company name &

Address

  

registration number

  

Batch number

  

Expiry date

  

Pack size

  

First distributed

  

Re-call Classification

  

Re-call Date
 

Adcock Ingram limited –

1 New road,

Midrand 1685, South Africa

  

B/2.7/1404

  

AC1369, AC1373, AC1441, AC1430

  

07/2022;

08/2022

  

5000’s

  

Dec 2020

  

Class II Type B

 13 July 2021

 

Reason for recall

The product was being recalled due to quality defect: Discoloration of tablets found in the batch.

 

Advice to HCPs/Distributors/Public:

The identified batches blocked for sale at Adcock Distribution centers and Hold Notification letter for Adco-Napamol tablets 5000’s was circulated to the Distributors and Wholesalers who bought directly from Adcock DCs. All stock of this batch must be immediately returned to your supplying wholesaler or distributor for full credit.

 

Reporting side effects

Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.

Download latest version
Version: 1
Date Updated: 13/07/2021
File Type: www
Category: Product Recall
Unit: Regulatory Compliance